Skip to main content
Jonathan Marotti, MD, Pathology, Lebanon, NH, Dartmouth-Hitchcock Medical Center

JonathanDMarottiMD

Pathology Lebanon, NH

Cytopathology, Anatomic Pathology, Clinical Pathology

Assistant Professor, Pathology, Geisel School of Medicine

Are you Dr. Marotti?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 39 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Jonathan Marotti, MD is a board certified pathologist in Lebanon, New Hampshire. He is currently licensed to practice medicine in New Hampshire, Vermont, and Massachusetts. He is affiliated with Dartmouth-Hitchcock Medical Center, White River Junction Veterans Affairs Medical Center, and Cheshire Medical Center.

Education & Training

  • Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital
    Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Cytopathology, 2010 - 2011
  • Beth Israel Deaconess Medical Center/Harvard Medical School Breast Pathology
    Beth Israel Deaconess Medical Center/Harvard Medical School Breast PathologyFellowship, Selective Pathology, 2009 - 2010
  • Beth Israel Deaconess Medical Center/Harvard Medical School
    Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Pathology-Anatomic and Clinical, 2005 - 2009
  • Geisel School of Medicine at Dartmouth
    Geisel School of Medicine at DartmouthClass of 2005

Certifications & Licensure

  • NH State Medical License
    NH State Medical License 2011 - 2025
  • VT State Medical License
    VT State Medical License 2013 - 2024
  • MA State Medical License
    MA State Medical License 2007 - 2013
  • American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • American Board of Pathology Cytopathology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Dartmouth Investigators Study Impact of Shift in Testing Guidelines for Assessing HER2 Status in Breast Cancer Patients
    Dartmouth Investigators Study Impact of Shift in Testing Guidelines for Assessing HER2 Status in Breast Cancer PatientsFebruary 12th, 2016

Hospital Affiliations